VivoSeq
Other

Muscle Cramp

24

Pipeline Programs

1

Active Trials

16

Companies Involved

Muscle Cramp is an emerging landscape with 24 programs across 16 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, Revance Therapeutics, Inc., Otsuka. 13 therapies are approved with 8 more in late-stage development.

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

0/100

Mech. Concentration

16/100

Completion Rate

83/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

12

clinical trials

Unknown status5 · 42%
Completed5 · 42%
Recruiting1 · 8%
Terminated1 · 8%

Trial Activity

12 trials

Mexiletine for the Treatment of Muscle Cramps in ALS
Completed··Phase 4·NCT01811355·23 enrolled
Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis
Unknown status·TTanta University·Phase 3·NCT02642861·200 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)